Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 344 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of... April 18, 2025 Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer June 4, 2020 Boy Born With Heart Defect Gets Surgery To Help It Triple... December 26, 2021 Brentuximab May Mean Less Radiation for Children, Teens with Hodgkin Lymphoma May 7, 2021 Load more HOT NEWS FDA Approves Talazoparib with Enzalutamide for HRR Gene-Mutated Metastatic Castration-Resistant Prostate... Microplastics Can Be Detected In Human Organ Tissue ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk... Getting Better Sleep When You Have Cancer-Related Insomnia: An Expert Q&A
